We investigated whether circulating levels of osteoprotegerin are related to features of CMV disease and treatment outcomes during CMV infection in @ solid organ transplant recipients receiving valganciclovir or ganciclovir in an international multicenter trial of CMV disease treatment ( the VICTOR study ) .